| Tretinoin | Approved Investigational Nutraceutical | PLA2G10 | 8399 |
upregulated | Tretinoin results in increased expression of PLA2G10 mRNA | 16p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | PLA2G12A | 81579 |
upregulated | Tretinoin results in increased expression of PLA2G12A mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | PLA2G2A | 5320 |
upregulated | Tretinoin results in increased expression of PLA2G2A mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | PLA2G4A | 5321 |
upregulated | Tretinoin results in increased expression of PLA2G4A mRNA | 1q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAC1 | 10761 |
downregulated | Tretinoin results in decreased expression of PLAC1 mRNA | Xq26.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAGL1 | 5325 |
upregulated | Tretinoin results in increased expression of PLAGL1 mRNA | 6q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAT | 5327 |
upregulated | Tretinoin metabolite results in increased expression of PLAT mRNA | 8p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAT | 5327 |
downregulated | Tretinoin results in decreased expression of PLAT mRNA | 8p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAT | 5327 |
upregulated | Tretinoin results in increased expression of PLAT mRNA | 8p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAU | 5328 |
downregulated | Tretinoin results in decreased expression of PLAU mRNA | 10q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAU | 5328 |
upregulated | Tretinoin results in increased expression of PLAU mRNA | 10q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLAUR | 5329 |
downregulated | Tretinoin results in decreased expression of PLAUR mRNA | 19q13 | |
| Tretinoin | Approved Investigational Nutraceutical | PLBD1 | 79887 |
upregulated | Tretinoin results in increased expression of PLBD1 mRNA | 12p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLCB1 | 23236 |
upregulated | Tretinoin results in increased expression of PLCB1 mRNA | 20p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PLCE1 | 51196 |
upregulated | Tretinoin results in increased expression of PLCE1 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | PLCXD1 | 55344 |
downregulated | Tretinoin results in decreased expression of PLCXD1 mRNA | Xp22.33 and Yp11.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PLCXD3 | 345557 |
downregulated | Tretinoin results in decreased expression of PLCXD3 mRNA | 5p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLCXD3 | 345557 |
upregulated | Tretinoin results in increased expression of PLCXD3 mRNA | 5p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLD1 | 5337 |
upregulated | Tretinoin results in increased expression of PLD1 mRNA | 3q26.31 | |
| Tretinoin | Approved Investigational Nutraceutical | PLD3 | 23646 |
upregulated | Tretinoin results in increased expression of PLD3 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLD5 | 200150 |
downregulated | Tretinoin results in decreased expression of PLD5 mRNA | 1q43 | |
| Tretinoin | Approved Investigational Nutraceutical | PLD6 | 201164 |
downregulated | Tretinoin results in decreased expression of PLD6 mRNA | 17p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEC | 5339 |
downregulated | Tretinoin results in decreased expression of PLEC mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEK | 5341 |
upregulated | Tretinoin results in increased expression of PLEK mRNA | 2p14 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEKHA5 | 54477 |
downregulated | Tretinoin results in decreased expression of PLEKHA5 mRNA | 12p12.3 | |